Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clearmind Medicine Inc. - Common Shares (NQ:CMND)

2.590 -0.130 (-4.78%)
Streaming Delayed Price Updated: 9:58 AM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clearmind Medicine Inc. - Common Shares

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Why Is Bed Bath & Beyond (BBBY) Stock Up 29% Today? ↗
Bed Bath & Beyond (BBBY) stock is on the rise Wednesday as investors continue to send the retailer's shares higher in a meme rally. 
Via InvestorPlace
News headline image
Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket ↗
Gainers Clearmind Medicine Inc. (NASDAQ: CMND) jumped 69.3% to $0.8480 in pre-market trading after dropping 12% on Tuesday. Clearmind Medicine recently announced a $3.5 million public offering priced... 
Via Benzinga
News headline image
Why Is Clearmind Medicine (CMND) Stock Up 47% Today? ↗
Clearmind Medicine (CMND) stock is on the rise with heavy trading Wednesday despite a lack of news from the psychedelic medicines company. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time for another dive into the biggest pre-market stock movers traders will want to know about on Wednesday morning! 
Via InvestorPlace
News headline image
Why iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket ↗
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) jumped 119.6% to $1.96 in pre-market trading. HeartCore forged an agreement with rYojbaba Inc for its tenth Go IPO consulting service win. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Pre-market stock movers are a hot topic on Wednesday as we dive into all of the latest news affecting markets this morning. 
Via InvestorPlace
News headline image
Why Is Virgin Orbit (VORB) Stock Down 27% Today? ↗
Virgin Orbit (VORB) stock is falling on Tuesday after the space travel company received a delisting notice from the Nasdaq Exchange. 
Via InvestorPlace
News headline image
Why Is PLx Pharma (PLXP) Stock Down 38% Today? ↗
PLx Pharma (PLXP) stock is taking a beating on Tuesday and there's a couple of reasons investors will want to know about its fall. 
Via InvestorPlace
News headline image
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear. 
Via Benzinga
News headline image
Why Is Clearmind Medicine (CMND) Stock Up 56% Today? ↗
Clearmind Medicine (CMND) stock is taking off on Tuesday with heavy trading despite a lack of news concerning the psychedelics company. 
Via InvestorPlace
News headline image
Why National CineMedia Shares Are Trading Higher By Around 111%; Here Are 20 Stocks Moving Premarket ↗
Gainers National CineMedia, Inc. (NASDAQ: NCMI) jumped 111.2% to $0.2810 in pre-market trading after a 13G filing showed a 9.1% passive stake in the company from AMC Entertainment. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting off the day with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on Tuesday! 
Via InvestorPlace
News headline image
Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Public Offering for Clearmind Medicine Inc. (NASDAQ: CMND)
Via ACCESSWIRE
News headline image
Clearmind Medicine Closes US$3.5 Million Public Offering
From Clearmind Medicine Inc.
Via GlobeNewswire
News headline image
How To Finance A Psychedelics Business? Learn From These Four Companies ↗
Clearmind Medicine Announces Pricing of $3.5 Million Public Offering 
Via Benzinga
News headline image
Dow Tumbles Over 200 Points; Butterfly Network Shares Spike Higher ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. The Dow traded down 0.64% to 33,387.61 while the NASDAQ fell 0.45% to 12,134.09. The S&P... 
Via Benzinga
News headline image
Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Secoo Holding Limited (NASDAQ: SECO) shares surged 138% to $1.43. 
Via Benzinga
News headline image
Gold Rises Sharply; AMC Entertainment Shares Plunge ↗
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 150 points on Tuesday. The Dow traded down 0.46% to 33,447.10 while the NASDAQ fell 0.30% to 12,152.44. The S&P 500,... 
Via Benzinga
News headline image
Why Clearmind Medicine Shares Are Nosediving ↗
Clearmind Medicine Inc (NASDAQ: CMND) shares are trading lower by 60.1% to $0.57 Tuesday morning after the company announced a $3.5 million public offering priced at $0.78 per share. The offering is... 
Via Benzinga
News headline image
Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering
From Clearmind Medicine Inc.
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time to dive into the biggest pre-market stock movers for Tuesday morning with all the latest news traders need to know about! 
Via InvestorPlace
News headline image
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered 
Via Benzinga
News headline image
A Drug That Mimics Alcohol Buzz Is Bound For Human Trials: Here's What's Next ↗
Israeli biotech Clearmind Medicine Inc. (NASDAQ: CMND) has submitted an Investigational New Drug (IND) application with the FDA towards approval to commence its first-in-human Phase 1/2a clinical trial... 
Via Benzinga
News headline image
Clearmind Medicine Submits IND Application to FDA for its Proprietary CMND-100 Treating Alcohol Use Disorder
From Clearmind Medicine Inc.
Via GlobeNewswire
News headline image
Clearmind Medicine Appoints Professor Henry R. Kranzler, M.D., to Scientific Advisory Board
From Clearmind Medicine Inc.
Via GlobeNewswire
News headline image
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash. 
Via Benzinga
News headline image
US Stocks Mostly Higher; Dow Rises 75 Points ↗
U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 75 points on Monday. Following the market opening Monday, the Dow traded up 0.24% to 31,986.55 while the NASDAQ rose... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday! 
Via InvestorPlace
News headline image
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets ↗
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.   
Via Benzinga
News headline image
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More ↗
Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and... 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.